entinostat

Briggs Morrison’s little biotech Syndax concedes 2 key trial setbacks for its lead drug, as shares shrivel some more
Endpoints
Thu, 03/7/19 - 09:43 pm
Syndax
Briggs Morrison
clinical trials
entinostat
Syndax is hit with a setback during the ASCO preview round as lead drug flops in mid-stage study
Endpoints
Fri, 05/18/18 - 12:17 pm
Syndax Pharma
HDAC inhibitors
entinostat
Keytruda
ASCO
Syndax shares soar as lead drug clears a mid-stage cancer drug study hurdle
Endpoints
Thu, 05/18/17 - 12:02 am
Syndax Pharma
clinical trials
entinostat
non-small cell lung cancer
Merck ties up with tiny Syndax on a 'breakthrough' cancer combo
Fierce Biotech
Tue, 03/31/15 - 12:40 pm
Merck
Syndax Pharma
entinostat
Keytruda
Syndax sets terms for a $69M IPO to support its 'breakthrough' drug
Fierce Biotech
Thu, 06/5/14 - 12:17 pm
Syndax Pharma
IPOs
breast cancer
breakthrough therapies
entinostat
Syndax Pockets $26.6M For Final Stage Push With Cancer Drug
Xconomy
Tue, 08/27/13 - 09:57 am
Syndax Pharma
entinostat
cancer